Rockville, MD, United States of America

Andrew M L Chan


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Bethesda, MD (US) (2001)
  • Rockville, MD (US) (2003 - 2009)

Company Filing History:


Years Active: 2001-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Andrew M L Chan

Introduction

Andrew M L Chan is a notable inventor based in Rockville, MD, with a focus on advancements in hepatocyte growth factor (HGF) research. He holds three patents that contribute significantly to the field of molecular biology and pharmaceutical compositions. His work is primarily associated with the National Institutes of Health, a component of the US Department of Health & Human Services.

Latest Patents

One of his latest patents is titled "Truncated hepatocyte growth factor variant protein HGF/NK2." This invention relates to a novel truncated form of hepatocyte growth factor (HGF) that specifically antagonizes the activity of HGF and also includes a partial HGF agonist. The patent details the purification, molecular cloning, and recombinant expression of these truncated HGF variants, along with their related pharmaceutical compositions. Additionally, it discusses the utilization of these small HGF variants to either inhibit or stimulate HGF mitogenesis in cells expressing the receptor for HGF. Another significant patent is "DNA encoding truncated hepatocyte growth factor variants," which shares similar themes and innovations as the first patent.

Career Highlights

Andrew M L Chan has made substantial contributions to the field of biomedical research through his innovative patents. His work at the National Institutes of Health has allowed him to explore the therapeutic potential of HGF variants, which could lead to advancements in treating various diseases.

Collaborations

He has collaborated with esteemed colleagues such as Jeffrey S Rubin and Stuart A Aaronson, further enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Andrew M L Chan's contributions to the field of hepatocyte growth factor research through his patents demonstrate his commitment to innovation and scientific advancement. His work has the potential to influence future therapeutic strategies in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…